[HTML][HTML] Анализ экспрессии генов иммунной системы, ответственных за активацию и ингибирование Т-клеточного иммунного ответа, у реципиентов …

ИБ Козлов, АВ Ватазин, АВ Кильдюшевский… - …, 2020 - cyberleninka.ru
Введение. В связи с растущей потребностью в трансплантации почки востребовано
применение новых методов профилактики отторжения трансплантата, базирующихся …

[PDF][PDF] Extracorporeal photoimmunotherapy-photopheresis

T Dani, R Knobler - Front Biosci, 2009 - article.imrpress.com
[Frontiers in Bioscience 14, 4769-4777, January 1, 2009] 4769 Extracorporeal
photoimmunotherapy-photopheresis Theresa Dani1, Rob Page 1 [Frontiers in Bioscience 14 …

Evaluation and Management of Skin Disease

N Hunzelmann, FV Castelino - Scleroderma: From Pathogenesis to …, 2024 - Springer
This chapter will review details on skin-directed evaluation and management in systemic
sclerosis (SSc) and localized scleroderma (or morphea) not covered in previous chapters …

Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs

C Franklin, K Bruderek, B Schilling… - Journal of Leukocyte …, 2019 - academic.oup.com
Extracorporeal photopheresis (ECP) is known as an immunomodulatory therapy with few
side effects, which is mainly used in the treatment of cutaneous T cell lymphoma, graft …

Leucocyte scintigraphy with 111In‐oxine for assessment of cell trafficking after extracorporeal photopheresis

U Just, E Dimou, R Knobler, G Klosner… - Experimental …, 2012 - Wiley Online Library
Extracorporeal photopheresis (ECP) is an established therapy for transplant rejection, graft‐
versus‐host disease (GvHD) after allogeneic stem cell transplantation, cutaneous T‐cell …

Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment

R Villela, SY Yuen, JE Pope… - Arthritis Care & Research …, 2008 - Wiley Online Library
Objective To determine the generalizability of randomized controlled trials (RCTs) in the
treatment of systemic sclerosis (SSc) using the Canadian Scleroderma Research Group …

Wirkweise, Indikationen und Therapieempfehlungen der extrakorporalen Photopherese (ECP)

A Cho, V Paulitschke, R Knobler - JDDG: Journal der …, 2023 - Wiley Online Library
Die extrakorporale Photopherese (ECP) hat in jüngster Zeit bei der Behandlung
verschiedener Krankheiten an Bedeutung gewonnen. Ursprünglich als neue Therapie zur …

Update on extracorporeal photopheresis

U Just, R Knobler - Der Hautarzt, 2015 - Springer
Bei der extrakorporalen Photopherese (ECP) handelt sich um ein von der PUVA-Therapie
abgeleitetes Therapiekonzept, das Leukapherese mit der Photochemotherapie verbindet …

[HTML][HTML] Extracorporeal photopheresis in dermatology

L Pérez-Carmona, A Harto-Castaño… - Actas Dermo …, 2009 - Elsevier
Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …

Disabling pansclerotic morphea of childhood

U Wollina, M Buslau, I Petrov… - Expert Review of …, 2007 - Taylor & Francis
Disabling pansclerotic morphea of childhood is a rare variant of deep morphea that shows a
different course from all other types of localized scleroderma. The majority of patients follow …